• Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Finland France Germany Italy Poland +2
  • Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

    Not yet recruiting

    2 1
    Investigated diseases:
    Spain
  • Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

    Not yet recruiting

    2 1
    Investigated diseases:
    Bulgaria Czechia France Germany Poland
  • Randomized trial of bupropion hydrochloride for fatigue in patients with long COVID (post‑COVID syndrome)

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • An observational study on the use of methotrexate in children and adolescents with Crohn’s disease

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Comparing human normal immunoglobulin (iv) and a drug combination to prevent infections in adults with B-cell acute lymphoblastic leukemia or B-cell lymphoma treated with CAR-T cells

    Not yet recruiting

    3 1 1 1
    France
  • Efficacy and Safety of Clemastine Fumarate in Children and Adults with Pitt‑Hopkins Syndrome: A Randomized Placebo‑Controlled Trial

    Not yet recruiting

    2 1 1
    Investigated drugs:
    The Netherlands
  • A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study of the efficacy and safety of ladarixin and rabbit anti-human thymocyte immunoglobulin in adolescents and adults with new-onset type 1 diabetes

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Italy

powered by